¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"alpha feedback"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
¿µ¹® feedback ÇÑ±Û µÇ¸ÔÀÓ
¼³¸í   
  ÀԷ°ú Ãâ·ÂÀ» °®Ãá Á¦¾î½Ã½ºÅÛ¿¡¼­ Ãâ·ÂÀÇ ÀϺθ¦ ÀÔ·ÂÃøÀ¸·Î µÇµ¹·Á ÀÔ·ÂÀ¸·Î »ç¿ëÇϴ ÀÏ. ÁõÆø±â³ª ÀÚµ¿ Á¦¾î µûÀ§ÀÇ Àü±âȸ·Î¿¡ ¸¹ÀÌ »ç¿ëÇÑ´Ù.
¿µ¹® alpha particles ÇÑ±Û ¾ËÆÄÀÔÀÚ
¼³¸í   
  ¿øÀÚ¿¡ Á¤»óº¸´Ù °ú´Ù, °ú¼ÒÇÑ Áß¼ºÀÚ³ª ¾çÀÚ¸¦ °¡Áö°í Àִ °æ¿ì¿¡ ¿øÀÚ°¡ ¾ÈÁ¤µÇ±â À§Çؼ­ ºØ±«°¡ »ý±ä´Ù. ÀÌ·± ºØ±«¿¡´Â ´ÙÀ½°ú °°Àº 3°¡Áö ¹æ¹ýÀÌ ÀÖ´Ù. ¾ËÆÄ£­ºØ±«´Â ¾ËÆÄÀÔÀÚ¸¦ ¹æÃâÇÏ¿© ¾ÈÁ¤µÇ´Â ¹ý, Áï ¿øÀÚ¹øÈ£´Â 2¾¿ °¨¼ÒÇϰí Áú·®¼ö´Â 4¾¿ °¨¼ÒÇÑ´Ù. ¾ËÆÄÀÔÀÚ¶õ ¾ËÆÄºØ±«¿¡ ÀÇÇØ¼­ »ý±â´Â Çï·ýÀÇ ÇÙ°ú °°Àº ÀÔÀÚ¸¦ ¸»ÇÑ´Ù.
  
  
¿µ¹® alpha-fetoprotein ÇÑ±Û ¾ËÆÄžƴܹé
¼³¸í   
  Å¾ÆÀÇ °£Á¶Á÷À̳ª ¼ÒÈ­±â°ü¿¡¼­ ¸¸µé¾îÁö´Â ´Ü¹éÁú. Å¾Ʊ⳪ ÀÓ»êºÎ¿¡¼­ Á¤»óÀûÀ¸·Î Á¸ÀçÇÑ´Ù. ±×·¯³ª °£¾Ï¼¼Æ÷³ª »ý½Ä¼¼Æ÷¿¡ °ü·ÃµÈ Á¾¾ç¿¡¼­µµ ¸¸µé¾îÁ® ÀÌ·± Áúº´ÀÌ Á¸ÀçÇÒ ¶§¿¡´Â ÀÓ»êºÎ³ª Å¾ư¡ ¾Æ´Ï´õ¶óµµ Á¶Á÷À̳ª Ç÷¾×¿¡ ³ªÅ¸³ª°Ô µÈ´Ù. ÀÓ»óÀûÀ¸·Î´Â °£¾ÏÀ̳ª »ý½Ä¼¼Æ÷ Á¾¾çÀÇ ¹ß°ß°ú Ä¡·áÈ¿°ú ÆÇÁ¤¿¡ ÀÌ¿ëµÇ°í, ¶Ç ÀӽŠ16~18ÁÖ¿¡ »ê¸ðÀÇ Ç÷¾×¿¡¼­ À̴ܹéÁúÀÇ ¾çÀ» ÃøÁ¤ÇÏ¿© Å¾ÆÀÇ ºñÁ¤»óÀûÀΠ¹ß´ÞÀ» ¹ß°ßÇÒ ¼ö ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • feedback
    µÇ¸ÔÀÓ
  • feedback circuit
    µÇ¸ÔÀÓȸ·Î
  • feedback inhibition
    µÇ¸ÔÀÓ¾ïÁ¦
  • negative feedback
    À½¼ºµÇ¸ÔÀÓ
  • negative feedback mechanism
    À½¼ºµÇ¸ÔÀÓ±âÀü
  • positive feedback
    ¾ç¼ºµÇ¸ÔÀÓ
  • regulatory motor feedback
    ¿îµ¿Á¶ÀýµÇ¸ÔÀÓ
  • alpha emitter
    ¾ËÆÄ¹æÃâü
  • alpha error
    ¾ËÆÄ¿À·ù, Á¦1Çü¿À·ù
  • alpha granule
    ¾ËÆÄ°ú¸³
  • alpha hemolysis
    ¾ËÆÄ¿ëÇ÷
  • alpha motor neuron
    ¾ËÆÄ¿îµ¿½Å°æ¼¼Æ÷
  • alpha ray
    ¾ËÆÄ¼±
  • alpha wave
    ¾ËÆÄÆÄ
  • alpha-adrenergics
    ¾ËÆÄ¾Æµå·¹³¯¸°¼º¾à
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • feedback
    µÇ¸ÔÀÓ
  • alpha-interferon
    ¾ËÆÄÀÎÅÍÆä·Ð
  • alpha-adrenergics
    ¾ËÆÄ¾Æµå·¹³¯¸°¼º¾à
  • alpha-fetoprotein
    ¾ËÆÄžƴܹé
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antibody feedback mechanism
    Ç×üµÇ¸ÔÀÓ±âÀü
  • feedback circuit
    µÇ¸ÔÀÓȸ·Î
  • delayed feedback test
    Áö¿¬Àç»ý°Ë»ç
  • feedback
    µÇ¸ÔÀÓ
  • feedback inhibition
    µÇ¸ÔÀÓ¾ïÁ¦
  • negative feedback
    À½¼ºµÇ¸ÔÀÓ
  • regulatory motor feedback
    ¿îµ¿Á¶ÀýµÇ¸ÔÀÓ
  • tubuloglomerular feedback
    ¿ä¼¼°ü»ç±¸Ã¼µÇ¸ÔÀÓ, ¿ä¼¼°üÅ丮µÇ¸ÔÀÓ
  • negative feedback mechanism
    À½¼ºµÇ¸ÔÀÓ±âÀü
  • alpha-chymotrypsin
    ¾ËÆÄÄ«ÀÌ¸ðÆ®¸³½Å
  • alpha-fetoprotein
    ¾ËÆÄžƴܹé
  • alpha-interferon
    ¾ËÆÄÀÎÅÍÆä·Ð
  • alpha-lipoproteinemia
    ¾ËÆÄÁö¹æ´Ü¹éÇ÷Áõ
  • alpha emitter
    ¾ËÆÄ¹æÃâ±â
  • alpha error
    Á¦ÀÏÁ¾¿À·ù
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Long-loop feedback
    Àåȯ(íóü») µÇ¸ÔÀ̱â
  • antibody feedback mechanism
    Ç×üµÇ¸ÔÀ̱â±âÀü.
  • informational feedback
    Á¤º¸ µÇ¸ÔÀÓ
  • 17-alpha-hydroxycorticosteroid
    17-¾ËÆÄ-È÷µå·Ï½ÃÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀ̵å
  • 17-alpha-hydroxyprogesterone
    17-¾ËÆÄ-È÷µå·Ï½ÃÇÁ·Î°Ô½ºÅ×·Ð
  • alpha behavior
    ¾ËÆÄÇàÀ§
  • alpha blocking
    ¾ËÆÄÂ÷´Ü
  • alpha cell
    ¾ËÆÄ¼¼Æ÷
  • alpha cell
    ¾ËÆÄ¼¼Æ÷(¡­á¬øà)
  • alpha cell glucagon cell
    ¾ËÆÄ¼¼Æ÷ ±Û·çÄ«°ï¼¼Æ÷
  • alpha cell tumor
    ¾ËÆÄ ¼¼Æ÷Á¾(¡­á¬øàðþ)
  • alpha chain disease
    ¾ËÆÄ¼âº´(¡­áðÜ»).
  • alpha chain disease
    ¾ËÆÄ¼âÁúȯ
  • alpha cradle
    ¾ËÆÄ¹Þħ´ë
  • alpha decay
    ¾ËÆÄºØ±«
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antibody feedback mechanism
    Ç×üµÇ¸ÔÀ̱â±âÀü.
  • delayed feedback test
    Áö¿¬Àç»ý°Ë»ç
  • feedback
    µÇ¸ÔÀ̱â, ±Íȯ(Ë´Ì·).
  • feedback circuit
    µÇ¸ÔÀ̱âȸ·Î(üÞÖØ), µÇ¸ÔÀÓȸ·Î (¡­üÞÖØ).
  • feedback inhibition
    µÇ¸ÔÀÓ¾ïÁ¦(åäð¤).
  • informational feedback
    Á¤º¸ µÇ¸ÔÀÓ
  • negative feedback
    À½¼ºµÇ¸ÔÀÓ
  • negative feedback inhibition
    À½¼ºµÇ¸ÔÀÓ¾ïÁ¦.
  • negative feedback mechanism
    À½¼ºµÇ¸ÔÀÓ±âÀü.
  • test, delayed feedback
    Áö¿¬Àç»ý°Ë»ç
  • tubuloglomerular feedback
    ¼¼´¢°ü»ç±¸Ã¼ µÇ¸ÔÀÓ
  • tubuloglomerular feedback
    ¼¼´¢°ü »ç±¸Ã¼ µÇ¸ÔÀ̱â
  • alpha (¥á) chain
    ¾ËÆÄ»ç½½, ¾ËÆÄ¼â
  • alpha (¥á) chain disease
    ¾ËÆÄ»ç½½º´, ¾ËÆÄ¼âº´
  • alpha (¥á) globulin
    ¾ËÆÄ±Û·ÎºÒ¸°
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Alpha cell [Glucagon cell]
    ¾ËÆÄ¼¼Æ÷ [±Û·çÄ«°ï¼¼Æ÷]
    [¿¾ ¿ë¾î] ¾ËÆÄ¼¼Æ÷
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • alpha adrenergic receptor
    ¾ËÆÄ¾Æµå·¹³ª¸°ÀÛµ¿¼º(íÂÔÑàõ) ¼ö¿ëü(áôé»ô÷)
  • alpha amanitin
    ¾ËÆÄ¾Æ¸¶´Ïƾ
  • alpha amino acid
    ¾ËÆÄ¾Æ¹Ì³ë»ê(ß«)
  • alpha blocker
    ¾ËÆÄÂ÷´ÜÁ¦(ó´Ó¨ð¥)
  • alpha bungarotoxin
    ¾ËÆÄºÐ°¡·ÎÅå½Å
  • alpha fraction
    ¾ËÆÄºÐȹ(ÝÂüñ)
  • alpha orientation
    ¾ËÆÄ¿À¸®¿£Å×À̼Ç
  • alpha receptor
    ¾ËÆÄ¼ö¿ëü(áôé»ô÷)
  • alpha tocopherol
    ¾ËÆÄÅäÄÚÆä·Ñ
  • bifunctional feedback
    ¾ç±â´É(å»Ñ¦Òö) µÇ¸ÔÀÓ
  • concerted feedback inhibition
    Çùµ¿(úðÔÒ) µÇ¸ÔÀÓ ÀúÇØ(îÁúª)
  • cooperative feedback inhibition
    Çùµ¿(úðÔÒ) µÇ¸ÔÀÓÀúÇØ(îÁúª)
  • cumulative feedback inhibition
    ´©Àû(׫îÝ) µÇ¸ÔÀÓ ÀúÇØ(îÁúª)
  • enzyme multiplicity feedback inhibition
    È¿¼Ò ´Ù¾ç¼º(ý£áÈÒýåÆàõ) µÇ¸ÔÀÓ ÀúÇØ(îÁúª)
  • feedback
    µÇ¸ÔÀÓ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • feedback
    µÇ¸ÔÀ̱â, ±Íȯ
  • alpha
    ¾ËÆÄ
  • alpha fetoprotein
    ¾ËÆÄžƴܹé
  • alpha ray
    ¾ËÆÄ¼±
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
alpha-GLUC alpha-glucosidase
AOA American Osteopathic Association; Administration on Aging; Alpha Omega Alpha Honor Society; American...
PAL pathology laboratory; peptidyl-alpha-hydroxyglycine alpha-amidating lysine phase alteration plane; p...
BFB biological feedback; bronchial foreign body
DAF decay-accelerating factor; delayed auditory feedback; drug-adulterated food
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
DAF Delayed Auditory Feedback
TGF Tubuloglomerular feedback
3 alpha-diol alpha-Androstan-3 alpha, 17 beta-diol
1 alpha(OH)D3 1 alpha hydroxyvitamin D3
1 alpha,25(OH)2D3 1 alpha, 25 dihydroxyvitamin D3
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • auditory feedback
    û°¢ Çǵå¹é, û°¢Àû µÇ¸ÔÀÓ
  • delayed feedback test
    Áö¿¬ Àç»ý °Ë»ç
  • feedback
    µÇ¸ÔÀ̱â, ±Íȯ, µÇ¸ÔÀÓ, Çǵå¹é
    ¾î¶² °úÁ¤À» Á¦¾îÇϱâ À§ÇÏ¿© Ãâ·ÂÀÇ ¾î¶² ºÎºÐÀ» ÀÔ·ÂÀ¸·Î µÇµ¹¸®´Â °Í.
  • feedback circuit
    µÇ¸ÔÀ̱â ȸ·Î, µÇ¸ÔÀÓ È¸·Î
  • feedback loop
    µÇ¸ÔÀÌ±â °í¸®, Çǵå¹é °í¸®
    ¾î¶² °úÁ¤À» Á¦¾îÇϱâ À§ÇÏ¿© Ãâ·ÂÀÇ ¾î¶² ºÎºÐÀ» ÀÔ·ÂÀ¸·Î µÇµ¹¸®´Â °Í.
  • feedback regulation
    ÇÇÀ̵å¹é ¾ïÁ¦
    Ç×ü°¡ Á¸ÀçÇÔÀ¸·Î½á ±× Ç×ü¿¡ ÀÇÇÑ negativeÀÇ ±â±¸°¡ À¯µµµÇ¾î °°Àº ƯÀ̼ºÀ» °¡Áø Ç×ü »ý»êÀÌ ¾ïÁ¦µÇ´Â Çö»ó.
  • negaive feedback mechanism
    À½¼º µÇ¸ÔÀ̱⠱âÀü
  • negative feedback inhibition
    À½¼º µÇ¸ÔÀ̱⠾ïÁ¦
  • neurologic feedback
    ½Å°æÇÐÀû µÇ¸ÔÀ̱â
  • positive feedback loop
    ¾ç¼º µÇ¸ÔÀÌ±â °í¸®, ¾ç¼º Çǵå¹é °í¸®
  • sensor feedback process
    °¨°¢¼º µÇ¸ÔÀÓ °úÁ¤
  • A alpha
    A ¾ËÆÄ, A ¾ËÆÄ ½Å°æ ¼¶À¯
  • A alpha primary afferent
    A ¾ËÆÄ ÀÏÂ÷ ±¸½É ½Å°æ
    ±Ù¹æÃß ³»ÀÇ ±Ù ¼¶À¯¿¡ Á¸ÀçÇÏ´Â °¨°¢½Å°æÀÇ Çϳª·Î ¥°a °¨°¢ ½Å°æÀ̶ó°íµµ ÇÑ´Ù. Á÷°æÀº 22§­, Àüµµ ¼Óµµ´Â 120§½ÀÌ´Ù.
  • A-alpha mechanoreceptor
    A ¾ËÆÄ ±â°è ¼ö¿ë±â
    ±Ù ¹æÃß¿Í °ñÁö °Ç ±â°ü¿¡ Á¸ÀçÇÑ´Ù.
  • alpha
    ¥á
    chain
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
positive feedback <physiology> The return of some of the output of a system as input so as to exert some control in the process.
(18 Nov 1997)
negative feedback This occurs where the products of a process can act at an earlier stage in the process to inhibit their own formation. The term was first used widely in conjunction with electrical amplifiers where negative feedback was applied to limit distortion of the signal by the amplification mechanism. Tends to stabilise the process. In contrast to positive feedback.
(18 Nov 1997)
feedback <physiology> The return of some of the output of a system as input so as to exert some control in the process.
(18 Nov 1997)
feedback activation The activation of an enzyme by an end product of a biochemical pathway in which that enzyme plays a part. For example, the activation of factors VIII and V by thrombin during blood clotting.
(05 Mar 2000)
feedback control The regulation of the activity of an enzyme by one of its products.
(09 Oct 1997)
feedback inhibition <biochemistry, physiology> The process of the end product of a particular metabolic reaction inhibiting an allosteric enzyme involved in that reaction as the reaction starts again, thus breaking the reaction cycle.
(09 Oct 1997)
feedback regulation <physiology> Control mechanism that uses the consequences of a process to regulate the rate at which the process occurs: if, for example: the products of a reaction inhibit the reaction from proceeding (or slow down the rate of the reaction), then there is negative feedback, something that is very common in metabolic pathways.
Positive feedback is liable to lead to exponential increase and may be explosively dangerous in some cases.
Other examples are the action of voltage dependent sodium channels in generating action potentials and the activation of blood clotting factors V and VIII by thrombin. Without damping, feedback can lead to resonance (hunting) and oscillation in the system.
(18 Nov 1997)
feedback system A complex of neuronal circuits whereby a part of the efferent path returns to the input to modulate its activity, thus acting as a governor on the system.
See: feedback.
(05 Mar 2000)
alpha, alpha-phosphotrehalase <enzyme> Forms glucose plus glucose-6-phosphate
Registry number: EC 3.2.1.93
Synonym: trehalose-6-phosphate hydrolase, phospho-alpha(1,1)glucosidase, trea gene product, trec gene product
(26 Jun 1999)
alpha,alpha-trehalose phosphorylase <enzyme> Chemical name: alpha-d-glucopyranosyl-alpha-d-glucopyranose orthophosphate glucosyltransferase
Registry number: EC 2.4.1.64
Synonym: trehalose phosphorylase
(26 Jun 1999)
alpha-dextrin endo-1,6-alpha-glucosidase <enzyme> An enzyme with action similar to that of isoamylase; it cleaves 1,6-alpha-glucosidic linkages in pullalan, amylopectin, and glycogen, and in alpha-and beta-amylase limit-dextrins of amylopectin and glycogen.
Compare: isoamylase.
Synonym: limit dextrinase, pullulanase, R enzyme.
(05 Mar 2000)
alpha-hydroxymethyl-alpha'-(N-acetylaminomethylene)succinic acid hydrolase <enzyme> Involved in degradation of vitamin b6; forms acetic acid plus ammonia plus carbon dioxide plus alpha-hydroxymethyl-succinic monoaldehyde
Registry number: EC 3.5.1.-
Synonym: compound b hydrolase
(26 Jun 1999)
cholesterol-5 alpha,6 alpha-epoxide hydrase <enzyme> Aspect of epoxide hydrolase, EC 3.3.2.3
Pharmacological action: carcinogen
Registry number: EC 3.3.2.-
Synonym: cholesterol epoxide hydrase, cholesterol epoxide hydrolase
(26 Jun 1999)
CMP-acetylneuraminate-alpha-N-acetylneuramide alpha-2,8-sialyltransferase <enzyme> Forms ganglioside gd3
Registry number: EC 2.4.99.8
Synonym: cmp-n-acetylneuraminate-gm3 sialyltransferase, gm3-sialosyltransferase, gd3 synthase, gd3-synthase, cmp-n-acetylneuraminate-(n-acetylneuraminyl)-d-galactosyl-d-glucosylceramide sialyltransferase, sialyltransferase II, st II, g(m3) alpha-2,8-sialyltransferase, st8sia I, stii enzyme, stiii enzyme, gt3 synthase
(26 Jun 1999)
CMP-N-acetylneuraminate-alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase <enzyme> Enzyme from foetal calf liver; forms branched tetrasaccharide, neuac-alpha2-3gal-beta1-3(neuac-alpha2-6)galnac of fetuin
Registry number: EC 2.4.99.3
Synonym: cmp-aag-sialyltransferase, st6galnaci, galnac 2,6-sialyltransferase
(26 Jun 1999)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • feedback
    Çǵå¹é(Ãâ·Â¿¡³ÊÁöÀÇ ÀϺθ¦ ÀÔ·ÂÀ¸·Î µÇµ¹¸®´Â Á¶ÀÛ);Á¾ÇÕÀÛ¿ë;¹ÝÇâ;Çǵå¹éÀÇ;Àç»ýÀÇ
  • feedback inhibition
    Çǵå¹é ÀúÇØ
  • negative feedback
    À½ µÇ¸ÔÀÓ;À½ Çǵå¹é
  • regenerative feedback
    Àç»ý Çǵå¹é(ÀÔ·Â À§»ó¿¡ ¸ÂÃß¾î µÇµ¹·Á º¸³»´Â)
  • alpha
    ¾ËÆÄ
  • alpha
    ±×¸®½ºÀÚ¸ðÀÇ Ã¹Â°±ÛÀÚ
  • alpha particle
    ¾ËÆÄÀÔÀÚ
  • alpha plus
    ÃÖ°í±ÞÀÇ
  • alpha rays
    ¾ËÆÄ¼±
  • alpha rhythm
    (³úÆÄÀÇ)¾ËÆÄ¸®µë
  • alpha test
    Áö´ÉÅ×½ºÆ®
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á